NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-018-2002-0-JP-07 Application of Spliceosome-Mediated RNA Trans-Splicing (SMART tm) Gene Therapy To The Treatment of Human Papillimavirus... JP National Stage 2005-3076 Expired
NIAMS E-355-2004-0-US-01 Tumor Necrosis Factor (TNF) Down Modulates The Suppressive Function Of CD4+CD25+ T Regulatory Cells gf US 60/641,990 Abandoned
NIAID E-048-2004-2-PCT-01 Compositions and Methods for the High Efficiency Expression of the Transforming Growth Factor-Beta Supergene Family PCT PCT COMB PCT/US2005/000378 Abandoned
NCI E-200-1998-0-US-37 Multidrug-Resistant Retroviral Protease Inhibitors, Compostions and Uses Thereof, Bioassay Methods, and Synthesis Methods US CON 11/030,632 Abandoned
NIAID E-046-2005-0-US-01 Methods and Compositions Related to the Identification of a Novel IL Inducing Protein Isolated from Toplasma gondii US 60/641,429 Abandoned
NIDDK E-324-2004-1-US-01 In Vitro Model For Hepatitis C Virion Production US 60/642,210 Abandoned
NCI E-144-2002-0-US-03 IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES US National Stage 10/513,725 7803913 Abandoned PDF
NHGRI E-167-2001-2-NZ-06 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium NZ National Stage 537505 Expired
NIAAA E-011-2004-2-PCT-01 Solid-Supported Membranes inside Porous Substrates and Their Use in Biosensors PCT PCT COMB PCT/US2005/00069 Expired
NCI E-221-1993-0-HK-21 Compositions and Methods for Therapy and Prevention of Cancer, Aids and Anemia HK EP 05100025.4 Abandoned
NCI E-221-1993-0-HK-19 Antiviral Composition Comprising Phenylacetic Acid Derivatives HK EP 05100026.3 Abandoned
CC E-311-2001-0-US-02 AUTOMATED CENTERLINE DETECTION ALGORITHM FOR COLON-LIKE 3D SURFACES US National Stage 10/500,342 7570802 Issued PDF
NHLBI E-211-2002-1-US-01 IL-21 As a Regulator of Immunoglobin Production US CIP 11/027,868 7332645 Expired PDF
NICHD E-028-2004-2-PCT-01 Novel IFN-gamma-Inducible Member of the Secretoglobin Family that Modulates Cellular Invasion and Migration PCT PCT COMB PCT/US2004/043717 Expired
NCI E-339-2004-0-US-01 Framework Residue Substituted Humanized COL-1 Antibodies and Their Use US 60/640,672 Abandoned
NCI E-221-1993-3-BA-29 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders BA EP 04030912.2 Abandoned
NINDS E-143-2002-1-JP-04 Method For the Treatment of Multiple Sclerosis JP National Stage 2004-518039 Abandoned
NINDS E-143-2002-0-JP-04 Method of Treating Autoimmune Diseases with Interferon-Beta and IL-2R Antagonist JP National Stage 2004-517494 Abandoned
NHLBI E-160-2002-0-JP-07 Trypotophan as a Functional Replacement for ADP-ribose-arginine in Recombinant Proteins JP National Stage 2004-518082 Abandoned
NINDS E-143-2002-1-IL-07 Method For the Treatment of Multiple Sclerosis IL National Stage 165973 Abandoned
NCI E-352-2004-2-US-01 Small Molecule And A Pharmacophore Model For Inhibition Of Anthrax Lethal Factor US ORD 11/017,771 7781183 Issued PDF
NINDS E-143-2002-0-US-03 METHOD OF TREATING AUTOIMMUNE DISEASES WITH INTERFERON-BETA AND IL-2R ANTAGONIST US National Stage 10/519,311 7575742 Abandoned PDF
NIDDK E-032-2004-0-PCT-02 Use of Parafibromin Antibodies to Diagnose Hyperparathyroidism-Jaw Tumor Syndrome (HPT-JT) and Parathyroid Cancer PCT PCT PCT/US2004/43512 Expired
NIDCR E-127-1995-1-US-03 METHOD OF MODULATING TISSUE GROWTH USING FRZB PROTEIN US CON 11/022,036 Abandoned
NIAID E-146-2004-0-US-01 Chimpaneze Monoclonal Antibody That Neutralizes Anthrax Protective Antigen (PA) Toxin US 60/639,074 Abandoned
NCI E-358-2004-0-US-01 Triptolide (TTP) As A Novel Molecule Tool To Induce The Suppression Of Human Dendritic Cell Maturation And Function, Which Favors The Induction Of Immune Tolerance US 60/638,640 Abandoned
NCI E-039-2004-3-PCT-01 Peptide Inhibitors of Retroviral Integrase Useful for The Treatment of Retrovial Infection PCT PCT COMB PCT/US2004/42726 Expired
NCI E-352-2004-0-PCT-02 Small Molecules and a Pharmacophore Model for Inhibitors of Anthrax Lethal Factor PCT PCT PCT/US04/043273 Expired
NIAID E-176-2003-0-PCT-02 Antibodies Against The Amino Terminus Region Of Circumsporozoite Protein Prevent The Onset Of Malaria Infection PCT PCT PCT/US04/043269 Expired
NICHD E-158-1998-0-US-08 VACCINE AGAINST ESCHERICHIA COLI 0157 INFECTION US CON 11/015,436 7247307 Abandoned PDF
NCI E-313-2001-0-US-04 Nucleic Acids of The Human ABCC12 Gene, Vector Containing Such Nucleic Acids And Uses Thereof US DIV 11/014,147 Abandoned
NCI E-152-2002-1-US-01 QUANTITATIVE ASSAY OF THE ANGIOGENIC AND ANTIANGIOGENIC ACTIVITY OF A TEST MOLECULE. US CIP 11/014,472 Abandoned
NCI E-144-2002-1-US-03 Identification of Novel Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies US National Stage 10/512,966 7566451 Abandoned PDF
NCI E-212-2004-0-US-01 Cancer-Specific SPAN-X -N Markers US 60/636,811 Abandoned
NCI E-121-2005-0-US-01 Polymer-linked Pseudomonas Exotoxin Immunotoxin US 60/636,007 Abandoned
NCI E-063-2002-0-FR-09 SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME FR EP 03734363.9 Abandoned
NCI E-063-2002-0-DE-08 SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME DE EP 03734363.9 Abandoned
NCI E-063-2002-0-GB-10 SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME GB EP 03734363.9 Abandoned
NIAID E-131-2002-0-US-02 Methods of treating and preventing colitis involving IL-13 and NK-T cells US National Stage 10/517,898 7666411 Abandoned PDF
NIAID E-168-2003-0-US-07 Protein Subunit Vaccine Against Orthopoxviruses US CON 11/010,979 7560116 Expired PDF
NIAID E-194-1999-0-US-05 Production Of Attenuated Respiratory Syncytial Virus Vaccines Involving Modification Of M2 ORF2 US CON 11/011,502 7485440 Abandoned PDF
NCI E-018-2002-0-AU-05 Spliceosome-Mediated RNA Trans-Splicing AU National Stage 2004237884 Abandoned
NCI E-188-1996-0-AU-11 MELANOMA CELL LINES EXPRESSING SHARED IMMUNODOMINANT MELANOMA ANTIGENS AND METHODS OF USING SAME AU DIV 2004237854 Expired
NCI E-311-2003-0-PCT-02 USE OF A PKC-DELTA INHIBITOR FOR THE INHIBITION OF METASTATIC MELANOMA PCT PCT PCT/US2004/041610 Expired
NCI E-090-2003-0-PCT-02 IMMUNOGENIC PEPTIDES OF XAGE-1 PCT PCT PCT/US2004/41639 Expired
NCI E-321-2003-0-AT-12 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 AT EP 04814140.2 Issued
NCI E-321-2003-0-BE-13 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 BE EP 04814140.2 Issued
NCI E-321-2003-0-CH-14 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 CH EP 04814140.2 Issued
NCI E-321-2003-0-GB-20 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 GB EP 04814140.2 Issued
NCI E-321-2003-0-DK-16 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 DK EP 04814140.2 Issued